TP53 and hepatocellular carcinoma: Somatic mutations in HCC were frequently observed regardless of degree of fibrosis in the background liver; CTNNB1 mutation was detected in 37.5%, TP53 mutation was 37.5%, and TERT promoter mutation was 50% in the HCC.